Velsera connects healthcare and life sciences to reveal the true promise of precision medicine — a continuous flow of knowledge between researchers, scientists, and clinicians around the world, fueling innovation and creating insights that radically improve human health.
Category:
Velsera
September 29th, 2022 by Almudena Ruiz-GimenezTern Therapeutics
September 28th, 2022 by Almudena Ruiz-GimenezTern Therapeutics was founded with a new vision for speeding the development of transformative, one-time genetic treatments for rare diseases.
SAB Biotherapeutics
September 24th, 2022 by Almudena Ruiz-GimenezSAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases.
Rockley Photonics
September 23rd, 2022 by Almudena Ruiz-GimenezFounded in 2013, Rockley Photonics Holding Limited develops and supplies silicon photonics in the United Kingdom and internationally.
PierianDx
September 20th, 2022 by Almudena Ruiz-GimenezPierianDx is a leading clinical genomics software solution provider for cancer hospitals/diagnostics labs to analyze and interpret genomics information for cancer patients.
Osigu
September 19th, 2022 by Almudena Ruiz-GimenezOsigu has developed a technology platform that aims to digitize and streamline the legacy medical insurance claim process in Latin America.